David Aronson is a cannabis educator who since 2018 has directly educated more than 5,000 health professionals nationwide on the medical applications of cannabis. He is on the faculty for PESI, one of the nation’s largest providers of professional continuing education, and he independently provides seminars for health professionals nationwide.

I learned during our conversation that David also has post-treatment Lyme disease, which is a condition that causes fatigue, neuropathic pain, brain fog, forgetfulness, and other chronic symptoms that he treats with cannabis. His experience made him curious whether others have found success using cannabis to treat persistent Lyme. He shared his findings at CannMed 24 as a poster presentation and with me in the conversation you are about to hear. 

We covered: 

• What is Lyme disease and how does one acquire it


• The different stages of Lyme disease 


• Treatments that are available to treat chronic Lyme disease 


• How David collected data for his study 


• Which types of products are effective for chronic Lyme symptoms 


• and more 

Thank You to This Episode’s Sponsor: McKinney RSA 

McKinney is made up of regulatory science veterans who apply lessons learned in the nicotine space to help cannabis manufacturers better understand the toxicological and societal implications of their product.  They do that by Identifying base compounds, extracts, flavors and terpenes, understanding how they interact, and ensuring effectiveness for the intended use. They also provide dosing recommendations and establish guidelines for product consistency. 

Learn more at mckinneyrsa.com 

Additional Resources

• lymedisease.org


• ilads.org


• strainprint.ca


• Review the Podcast!


• CannMed Archive